Cargando…
Angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities()
► Ovarian angiosarcomas are rare and clinically aggressive neoplasms. ► In addition to surgery, taxol is the most studied adjuvant chemotherapy. ► Anti-angiogenic therapies can be considered as an option.
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862320/ https://www.ncbi.nlm.nih.gov/pubmed/24371690 http://dx.doi.org/10.1016/j.gynor.2013.02.001 |
_version_ | 1782295734224158720 |
---|---|
author | Albertin, Cassandra Johnson, Karen A. Connor, Joseph P. Al-Niaimi, Ahmed N. |
author_facet | Albertin, Cassandra Johnson, Karen A. Connor, Joseph P. Al-Niaimi, Ahmed N. |
author_sort | Albertin, Cassandra |
collection | PubMed |
description | ► Ovarian angiosarcomas are rare and clinically aggressive neoplasms. ► In addition to surgery, taxol is the most studied adjuvant chemotherapy. ► Anti-angiogenic therapies can be considered as an option. |
format | Online Article Text |
id | pubmed-3862320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-38623202013-12-26 Angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities() Albertin, Cassandra Johnson, Karen A. Connor, Joseph P. Al-Niaimi, Ahmed N. Gynecol Oncol Case Rep Case Report ► Ovarian angiosarcomas are rare and clinically aggressive neoplasms. ► In addition to surgery, taxol is the most studied adjuvant chemotherapy. ► Anti-angiogenic therapies can be considered as an option. Elsevier 2013-02-11 /pmc/articles/PMC3862320/ /pubmed/24371690 http://dx.doi.org/10.1016/j.gynor.2013.02.001 Text en © 2013 The Authors http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Case Report Albertin, Cassandra Johnson, Karen A. Connor, Joseph P. Al-Niaimi, Ahmed N. Angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities() |
title | Angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities() |
title_full | Angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities() |
title_fullStr | Angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities() |
title_full_unstemmed | Angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities() |
title_short | Angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities() |
title_sort | angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities() |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862320/ https://www.ncbi.nlm.nih.gov/pubmed/24371690 http://dx.doi.org/10.1016/j.gynor.2013.02.001 |
work_keys_str_mv | AT albertincassandra angiosarcomaoriginatingfromanovarianmatureteratomaararediseasewithcomplextreatmentmodalities AT johnsonkarena angiosarcomaoriginatingfromanovarianmatureteratomaararediseasewithcomplextreatmentmodalities AT connorjosephp angiosarcomaoriginatingfromanovarianmatureteratomaararediseasewithcomplextreatmentmodalities AT alniaimiahmedn angiosarcomaoriginatingfromanovarianmatureteratomaararediseasewithcomplextreatmentmodalities |